Cargando…
Pharmaceutical Interventions for Inpatients with Liver Cirrhosis and Liver Transplantation: A Systematic Review of Experimental Studies
Liver cirrhosis, which is considered one of the leading causes of death in the world, can lead to severe complications, and is often followed by a liver transplantation. These patients take an average of nine medications daily. If not managed adequately, it can be accompanied by serious drug-related...
Autores principales: | Jibai, Nagham, Koch, Alexander, Ulmer, Tom Florian, Erdmann, Pia, Koeck, Joachim Andreas, Eisert, Albrecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671912/ https://www.ncbi.nlm.nih.gov/pubmed/38002644 http://dx.doi.org/10.3390/jcm12227030 |
Ejemplares similares
-
EXPERIMENTAL CIRRHOSIS OF THE LIVER
por: Pearce, Richard M.
Publicado: (1906) -
Comparison of Drug-Related Problems in COVID-19 and Non-COVID-19 Patients Provided by a German Telepharmacy Service for Rural Intensive Care Units
por: Koeck, Joachim Andreas, et al.
Publicado: (2023) -
Fecal Microbiota Transplantation in Liver Cirrhosis
por: Boicean, Adrian, et al.
Publicado: (2023) -
Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015) -
TREATMENT OF EXPERIMENTAL DIETARY CIRRHOSIS OF THE LIVER IN RATS
por: György, Paul, et al.
Publicado: (1949)